Trinity Biotech to Announce Q2 2024 Results
Trinity Biotech will release its Q2 2024 financial results on August 14, 2024, with a call at 8:30 AM ET ...
- Latest
- Trending
Trinity Biotech will release its Q2 2024 financial results on August 14, 2024, with a call at 8:30 AM ET ...
Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
ATSG reports strong Q2 2024 growth, raises EBITDA outlook, expands Amazon partnership with more aircraft.
Nikola Corp sees growth in hydrogen trucks, reports losses. Aiming for 14 fuel stations in North America by end of ...
Exchange Income Corporation reports robust Q2 2024 results, driven by aerospace and aviation. Strategic growth bolstered by key acquisitions.
New Fortress Energy reports lower than expected Q2 2024 earnings. FLNG 1 operational, promising $500 million annual boost.
Goldman Sachs BDC reports Q2 mixed results, dividend $0.45/share, net income up, asset value down, plans for strategic investments.
Bitfarms reports revenue drop but eyes growth in HPC/AI with $195M liquidity.
Purple Innovation sees sales increase, revises revenue outlook downwards, highlights profitability improvements and cost management.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.